Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin
J. Wong, S. Sridharan, J. Berdeprado, and et al. Predicting residual kidney function in hemodialysis patients using serum β-trace protein and β2-microglobulin Kidney Int 89 2016 1090 1098
Estimating residual kidney function in dialysis patients without urine collection
T. Shafi, W.M. Michels, A.S. Levey, and et al. Estimating residual kidney function in dialysis patients without urine collection Kidney Int 89 2016 1099 1110
Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients
T.M. Pickett, A. Cruickshank, R.N. Greenwood, and et al. Membrane flux not biocompatibility determines beta-2-microglobulin levels in hemodialysis patients Blood Purif 20 2002 161 166
Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients
T. Gerhardt, U. Poge, and B. Stoffel-Wagner Serum levels of beta-trace protein and its association to diuresis in haemodialysis patients Nephrol Dial Transplant 23 2008 309 314
Determination of the production rate and non-renal clearance of cystatin C and estimation of glomerular filtration rate from the serum concentration of cystatin C in humans
P. Sjostrom, M. Tidman, and I. Jones Determination of the production rate and non-renal clearance of cystatin C and estimation of glomerular filtration rate from the serum concentration of cystatin C in humans Scand J Clin Lab Invest 65 2005 111 124
Differences in prescribed Kt/V and delivered haemodialysis dose - why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target
A. Davenport Differences in prescribed Kt/V and delivered haemodialysis dose - why obesity makes a difference to survival for haemodialysis patients when using a 'one size fits all' Kt/V target Nephrol Dial Transplant 28 suppl 4 2013 iv219 iv223